Cognex Corp Form 4 Filings

COGNEX CORP Vice President Darren Marc Long reported equity compensation activity involving restricted stock units and related common stock. On August 7, 2026, 2,500 restricted stock units were exercised into 2,500 shares of common stock at a conversion price of $0.00 per share. In connection with this vesting, 734 common shares were delivered or withheld at $66.89 per share to satisfy tax withholding obligations, while the remaining shares from the vesting event were retained.

The filing also lists ongoing direct holdings of multiple non-qualified stock options on Cognex common stock, with exercise prices ranging from $33.04 to $64.43 per share and expirations between 2032 and 2036, covering underlying share amounts such as 34,271 and 31,095. Additional unvested restricted stock units remain outstanding with scheduled vesting through 2029.

COGNEX CORP CEO and President Matthew Moschner reported equity compensation activity on August 7, 2026. 4,999 restricted stock units were exercised into the same number of common shares, with 2,218 shares withheld at $66.89 per share to satisfy tax withholding obligations. He continues to hold multiple non-qualified stock option grants and restricted stock units covering substantial additional shares of Cognex common stock.

Cognex Corp vice president Darren Marc Long reported a combination of option exercises and share sales in company stock. On May 27, 2026, he exercised non-qualified stock options covering 18,673 shares of common stock at strike prices of $49.12, $51.49, and $56.44 per share.

On the same date, he completed open-market sales totaling 20,252 shares of common stock at prices of $66.5201 and $66.3215 per share. After these transactions, Long directly held 5,569 shares of Cognex common stock. The filing also lists prior grants of stock options and restricted stock units as part of his ongoing equity compensation.

COGNEX CORP Chief Legal Officer & Secretary Mark Fennell reported a series of option exercises and related share sales in Common Stock. On May 11, 2026, he exercised options to acquire a total of 60,010 shares at exercise prices ranging from $33.04 to $56.44 per share. On the same date, he executed open-market sales totaling 64,873 shares at prices including $66.73 and $67.08 per share. Following these transactions, Fennell directly holds 4,863 shares of Cognex Common Stock. Footnotes describe prior option grants that vest in annual installments over several years.

Cognex Corp VP and PAO Laura Ann Macdonald reported a series of option exercises paired with open‑market sales of Common Stock on May 11–12, 2026. She sold a total of 139,722 shares of Common Stock in open‑market transactions at prices including $66.8022 and $65.5632 per share.

These sales followed exercises of stock options covering 137,510 shares at strike prices ranging from $33.04 to $56.44 per share. After the transactions, she holds 5,258 Common shares directly, plus equity awards such as Restricted Stock Units and Non‑Qualified Stock Options, including 11,211 RSUs and options for 23,891 shares at an exercise price of $64.43. An additional 20 shares are held indirectly by her child, for which she disclaims beneficial ownership except for any pecuniary interest.

COGNEX CORP SVP and CFO Dennis Fehr reported routine equity compensation activity involving restricted stock units and common shares. He exercised derivative rights tied to 5,394 shares of common stock, increasing his direct holdings through a derivative exercise rather than an open-market purchase.

To cover related tax obligations on vested restricted stock units, 1,984 common shares were withheld, described as payment of tax liability by delivering securities. After these transactions, he directly holds 15,988 common shares, along with multiple outstanding restricted stock units and non-qualified stock options that may convert into additional Cognex common stock over future vesting and exercise periods.

Cognex Corp VP and principal accounting officer Laura Ann MacDonald reported routine equity compensation activity. On March 15, 2026 she exercised 368 restricted stock units, receiving an equal number of common shares. Of these, 109 shares were automatically withheld at a price of $47.98 per share to cover tax obligations, leaving her with 7,470 common shares held directly after the transactions. Each restricted stock unit represents a right to one Cognex common share, and the grant vests approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the March 15, 2024 grant date.

Cognex director Dianne M. Parrotte exercised multiple non-qualified stock options on March 2, 2026 and immediately sold the resulting shares. She acquired 44,000 shares of Cognex common stock through option exercises at strike prices around $45–$51.49, then sold 44,000 shares in open-market transactions at $54.00 per share. After these transactions, she directly owned 33,431 Cognex common shares.

Cognex Corp director Dianne M. Parrotte increased her direct ownership through an equity award event. On February 21, 2026, she exercised or converted 2,913 Restricted Stock Units into 2,913 shares of Cognex common stock at a stated price of $0.0000 per share, indicating no cash outlay in this transaction. Following the conversion, her directly held common stock position rose to 33,431 shares. The filing also reports outstanding Non-Qualified Stock Options with direct ownership covering 7,500, 18,400, and 18,100 shares, which remain as rights to buy stock.

Cognex Corp director Angelos Papadimitriou reported a mix of stock transactions. On February 23, 2026, he sold 4,150 shares of common stock in an open-market transaction at an average price of $55.5804 per share, leaving 16,222 common shares directly owned.

On February 21, 2026, restricted stock units covering 2,537 shares were exercised and converted into the same number of common shares at no cash exercise price, increasing his common stock before the sale to 20,372 shares. Following these transactions, he also directly holds 4,817 restricted stock units that vest over time under a prior grant.

COGNEX CORP director John Tseng-Chung Lee exercised restricted stock units into common shares. He converted 2,913 restricted stock units into 2,913 shares of common stock at a stated price of $0.00 per share. After these transactions, he directly holds 24,820 common shares and 4,817 restricted stock units, which will vest over time based on the original grant schedule.

Cognex Corporation director Marjorie Sennett reported the exercise and conversion of 2,913 restricted stock units into an equal number of Cognex common shares at a price of $0.00 per share. After this transaction, she directly holds 25,936 common shares and 4,817 restricted stock units.

The restricted stock units each represent a contingent right to receive one share of common stock and vest in stages of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.

COGNEX CORP director Sachin Lawande exercised restricted stock units into common shares. On February 21, 2026, he converted 2,913 restricted stock units into 2,913 shares of Cognex common stock at $0.00 per share through a derivative exercise.

After this transaction, he directly held 28,431 shares of common stock and 4,817 restricted stock units. Each restricted stock unit represents a right to receive one share of Cognex common stock, and these units vest 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.

Cognex director Anthony Sun reported an equity award transaction involving restricted stock units (RSUs) and common shares. On February 21, 2026, he exercised 2,913 RSUs, converting them at $0.00 per unit into 2,913 shares of Cognex common stock held directly. Following this conversion, his directly held common stock position reported in this filing is 335,085 shares, while the exercised RSU grant balance is now 0 units.

The filing also lists additional indirect holdings through Sun Management Associates, LLC, including several non-qualified stock options with reported remaining amounts ranging from 13,000 to 26,000 shares and 52,608 shares of common stock. A footnote states that Sun is a member of this LLC and disclaims beneficial ownership of those securities except to the extent of his pecuniary interest. Another footnote explains that each RSU represents a contingent right to receive one share of Cognex common stock and that the applicable RSU award vests 20%, 30%, and 50% on the first, second, and third anniversaries of its February 21, 2023 grant date.

Cognex Corporation CEO & President Matthew Moschner reported equity compensation activity involving restricted stock units and related tax withholding. On February 20 and 21, 2026, restricted stock units covering 3,042 and 3,495 shares were exercised into an equal number of Cognex common shares at $0.00 per share.

To satisfy tax withholding obligations on these vesting awards, 893 and 1,026 common shares were automatically withheld at a price of $56.03 per share, as described in the footnotes. After these transactions, Moschner held 16,465 shares of Cognex common stock directly, along with multiple outstanding non-qualified stock options and additional restricted stock units.

COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales. On February 20–21, 2026, he exercised multiple non-qualified stock options and restricted stock units, receiving Cognex common stock through derivative exercises at stated exercise prices such as $33.04, $38.39, and $39.44 per share.

He then sold a total of 61,900 shares of common stock in open-market transactions at prices around $55.98–$56.24, and some additional shares were disposed of to satisfy tax withholding obligations on vested restricted stock units, as described in the footnotes. After these transactions, Kuechen directly owned 6,032 shares of Cognex common stock.

Cognex EVP Carl Gerst reported a series of stock transactions involving Cognex common shares and restricted stock units. On February 20, 2026, he exercised restricted stock units into 6,846 common shares and another 6,846 common shares, then had 2,010 shares withheld to cover tax obligations and sold 3,804 shares in open‑market trades at about $55.99 per share. On February 21, 2026, additional restricted stock units converted into 8,791 common shares, with 3,095 shares withheld for taxes. On February 23, 2026, he sold 10,532 common shares in open‑market transactions at an average price of about $55.93 per share under a Rule 10b5‑1 trading plan. After these trades, his reported direct common‑stock holdings were 0 shares, while the filing notes outstanding restricted stock units that vest 20%, 30%, and 50% on the first, second, and third anniversaries of the 2023 and 2024 grant dates.

Cognex Corporation vice president and principal accounting officer Laura Ann Macdonald reported routine equity compensation activity. On February 20, 2026 and February 21, 2026, restricted stock units converted into 1,902 and 2,754 shares of common stock, respectively, through derivative exercises at a stated price of $0.00 per share.

To satisfy tax withholding obligations on these vestings, 559 and 809 common shares were automatically withheld at $56.03 per share, as described in the footnotes. Following these transactions, Macdonald directly held 7,211 Cognex common shares, along with multiple non-qualified stock option and restricted stock unit positions. An additional 20 common shares are held indirectly by her child, with beneficial ownership disclaimed except for any pecuniary interest.

Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported the vesting of restricted stock units and related tax withholding transactions. On February 20, 2026 and February 21, 2026, she acquired a total of 9,098 shares of common stock through exercises of restricted stock units, each unit converting into one share.

To cover tax withholding obligations on these vested awards, 1,117 shares on February 20, 2026 and 1,555 shares on February 21, 2026 were disposed of at $56.03 per share, as share-withholding rather than open-market sales. After these transactions, she directly owned 15,013 shares of Cognex common stock.

COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.

The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.

COGNEX CORP CEO & President Matthew Moschner reported equity awards and vesting activity. On February 18, 2026, 5,085 restricted stock units converted into common stock, with 1,600 shares withheld at $56.7200 per share to satisfy tax withholding obligations.

On February 17, 2026, he received 58,744 non-qualified stock options at an exercise price of $57.0900 and 56,928 restricted stock units, which vest over future anniversaries of the grant date. Following these events he directly holds 93,874 restricted stock units, 11,847 common shares, and options for 697,280 shares.

Cognex Corporation senior vice president and chief financial officer Dennis Fehr reported several equity compensation movements. On February 17, 2026, he was granted 25,306 non-qualified stock options and 24,523 restricted stock units, both at a price of $0.00 per unit. The options vest in five approximately equal annual installments beginning one year after the grant date, while the restricted stock units vest 20%, 30%, and 50% over three years.

On February 18, 2026, 5,085 restricted stock units were converted into the same number of common shares, and 1,618 common shares were disposed of to satisfy tax withholding obligations at $56.72 per share. Following these transactions, Fehr directly owned 14,196 common shares and held 20,339 restricted stock units, along with substantial option holdings.

COGNEX CORP director Angelos Papadimitriou reported equity awards and conversions. On February 18, 2026, he exercised 8,324 restricted stock units at $0.0000 per share into the same number of common shares, bringing his direct common stock holdings to 17,835 shares. On February 17, 2026, he received a grant of 4,817 restricted stock units, which each represent a contingent right to one Cognex common share and vest 100% on the first anniversary of the grant date.

Cognex Corporation’s Chief Technology Officer, Joerg Kuechen, reported several equity-related transactions. On February 18, 2026, 4,056 restricted stock units were converted into an equal number of common shares at $0.00 per share, and 1,327 of those shares were disposed of at $56.72 per share to cover tax withholding obligations rather than through an open‑market sale. After these transactions, he directly held 2,729 shares of common stock. On February 17, 2026, he also received a direct grant of 8,759 new restricted stock units, which vest 100% on the second anniversary of the grant date. Additional non‑qualified stock options and restricted stock units are listed as existing holdings, reflecting his broader long‑term incentive position.

COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares. On February 18, 2026, he exercised 8,324 restricted stock units for 8,324 shares of common stock at a price of $0.00 per share, bringing his direct common stock holdings to 21,907 shares.

On February 17, 2026, he received a grant of 4,817 restricted stock units, and a separate line shows 2,913 restricted stock units held directly after another transaction. Each restricted stock unit represents the right to receive one share of Cognex common stock, with footnotes indicating these awards vest 100% on the first anniversary of their respective grant dates.

COGNEX CORP director Marjorie Sennett reported equity award activity involving restricted stock units and common shares. On February 18, 2026, restricted stock units covering 8,324 shares were exercised for common stock at $0.0000 per share, leaving 23,023 common shares held directly.

On February 17, 2026, she received a grant of 4,817 restricted stock units, each representing a contingent right to one share of common stock. Footnotes state that certain restricted stock unit awards vest 100% on the first anniversary of their respective grant dates.

COGNEX CORP director Sachin Lawande reported equity awards and an RSU conversion. On February 18, 2026, 8,324 restricted stock units were exercised or converted into 8,324 shares of common stock at a stated price of $0.00 per share, leaving 25,518 common shares held directly.

On February 17, 2026, Lawande received a grant of 4,817 restricted stock units, each representing a contingent right to one share of Cognex common stock. Footnotes state that one RSU grant vests 100% on the first anniversary of the February 18, 2025 grant date, and another vests 100% on the first anniversary of the February 17, 2026 grant date.

COGNEX CORP executive Carl Gerst reported multiple equity award transactions. On February 17, 2026, he received a grant of 24,854 non-qualified stock options and 24,085 restricted stock units (RSUs), each at a price of $0.00 per share.

The options vest in five approximately equal annual installments on the first through fifth anniversaries of the February 17, 2026 grant date. The RSUs granted on that date vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. Each RSU represents a contingent right to receive one share of Cognex common stock.

On February 18, 2026, 5,570 RSUs vested and were converted into 5,570 shares of common stock. Of these, 1,766 shares were withheld at $56.72 per share to satisfy tax withholding obligations, leaving 3,804 common shares directly held afterward.

Cognex Corp VP and principal accounting officer Laura Ann Macdonald reported multiple equity transactions. On February 17, 2026, she received a grant of 7,231 non-qualified stock options and 11,211 restricted stock units (RSUs), each RSU representing the contingent right to one common share. The options vest in five approximately equal annual installments beginning on the first anniversary of the grant date, while the RSUs vest 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date.

On February 18, 2026, 2,422 RSUs vested and were converted into the same number of common shares. Of these, 711 shares, valued at $56.72 per share, were withheld to satisfy tax withholding obligations, leaving her with 3,923 directly held common shares and 9,685 RSUs. An additional 20 common shares are held indirectly by her child, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.

Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported several equity compensation transactions. On February 17, 2026, she received a grant of 13,557 non-qualified stock options and 13,138 restricted stock units (RSUs), both at a price of $0.00. The options vest in five approximately equal annual installments starting one year after the grant date, while the RSUs vest 20%, 30%, and 50% on the first, second, and third anniversaries.

On February 18, 2026, 3,027 RSUs were exercised and converted into common stock at $0.00, increasing her directly held common shares, and 1,022 common shares at $56.72 were withheld to satisfy tax obligations related to the vesting. After these transactions, she held 8,587 shares of common stock directly and maintained derivative holdings including RSUs and stock options as reported.

COGNEX CORP director Robert Willett reported equity award activity tied to restricted stock units that vested on February 18, 2026. A total of 14,165 restricted stock units were converted into common shares at no cost and are held indirectly by the Willett Parkhill Investment Trust, where he is trustee and beneficiary and disclaims beneficial ownership beyond his economic interest.

To cover tax obligations on this vesting, the trust disposed of 6,849 common shares at $56.72 per share through share withholding rather than an open-market sale. The underlying RSU grant vests in tranches of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 18, 2025 grant date.

Cognex director Anthony Sun reported equity award activity and updated holdings. On February 18, 2026, 8,324 restricted stock units were exercised or converted at an exercise price of $0.00 per unit, resulting in 8,324 shares of common stock and bringing his directly held common stock to 332,172 shares.

On February 17, 2026, Sun received a grant of 4,817 restricted stock units, which each represent a right to one share of Cognex common stock and vest 100% on the first anniversary of the grant date. The filing also lists stock options and common shares held indirectly through Sun Management Associates, LLC, where he disclaims beneficial ownership beyond his pecuniary interest.

Cognex Corp director Robert Willett exercised stock options and sold the resulting shares in a same-day transaction. On 02/13/2026 he exercised 2,148 non-qualified stock options at $39.44 per share, receiving 2,148 shares of common stock, then sold those 2,148 shares at an average price of $59.5011 per share under a Rule 10b5-1 trading plan. Following these transactions he reported no directly held common shares, while continuing to hold multiple option grants and restricted stock units, plus 15,804 common shares held indirectly through the Willett Parkhill Investment Trust, where he is trustee and beneficiary and disclaims beneficial ownership beyond his pecuniary interest.

Cognex director Robert Willett reported exercising stock options and selling the resulting shares on 02/12/2026. He exercised options for 173,296 shares at $38.39 and 3,756 shares at $39.44, then sold all 177,052 shares of common stock at an average price of $58.3851 per share in open-market transactions.

The filing shows remaining direct holdings of multiple non-qualified stock options covering hundreds of thousands of shares with exercise prices from $33.04 to $90.5, plus 70,824 restricted stock units and 15,804 shares held indirectly by a trust where Willett is trustee and beneficiary. The stock option exercises were carried out under a pre-established Rule 10b5-1 trading plan.

Cognex Corp VP and PAO Laura A. MacDonald reported option exercises and share sales on 02/12/2026. She exercised 12,500 non-qualified stock options at $38.39 per share, receiving an equal number of common shares.

MacDonald then made open-market sales totaling 14,881 common shares: 2,381 shares at $56.56 and 12,500 shares at $57.2707, pursuant to Rule 10b5-1 trading plans. After these transactions, she directly owned 2,212 common shares, plus various option and restricted stock unit awards, and 20 shares were held indirectly by her child with beneficial ownership disclaimed except for any pecuniary interest.

Cognex director Anthony Sun reported an indirect option exercise through Sun Management Associates, LLC. On January 8, 2026, the LLC exercised a non-qualified stock option for 26,000 shares of Cognex common stock at an exercise price of $16.72 per share, increasing its indirect common stock holdings to 52,608 shares. Separately from the LLC holdings, Sun is shown with 323,848 shares of common stock held directly, along with direct holdings of restricted stock units covering 8,324 and 2,913 shares. Following the exercise, the specific option grant for 26,000 shares is reduced to zero, while the LLC continues to hold additional non-qualified stock options for 26,000, 23,000, 26,000, and 13,000 shares at higher exercise prices. The filing notes that Sun is a member of the LLC and disclaims beneficial ownership of the LLC-held securities except to the extent of his pecuniary interest.

Cognex (CGNX) director Robert Willett reported an option exercise and same‑day sale. On 10/21/2025, he exercised 6,704 non-qualified stock options at an exercise price of $38.39 per share and sold 6,704 common shares at an average price of $49.5062. The transactions were effected pursuant to a Rule 10b5‑1 trading plan.

Following these transactions, the filing shows 0 shares held directly and 15,804 shares held indirectly by a trust. The report also lists multiple outstanding option grants and a restricted stock unit award, reflecting ongoing equity incentives with stated vesting and expiration dates.